Lenze named head of Department of Psychiatry

Eric J. Lenze, MD, a leader in the treatment of psychiatric disorders in older adults and in devising innovative clinical trials to answer pressing public health problems, has been named the head of the Department of Psychiatry at Washington University School of Medicine in St. Louis. He will begin his new role Aug. 1. Lenze is the […]

$12.2 million to fund new Conte Center to study neurosteroids

The National Institute of Mental Health (NIMH) has awarded Washington University School of Medicine in St. Louis a five-year, $12.2 million grant to create a center aimed at advancing research into neurosteroids as treatments for depression and other psychiatric disorders. The new Silvio O. Conte Center for Basic Neuroscience Research will be one of only […]

New antidepressants on horizon

More than 14 million Americans suffer from clinical depression, yet one in three doesn’t experience relief from approved antidepressant drugs. A new treatment approach involving drugs called neurosteroids is on the horizon, however. Neurosteroids occur naturally in the brain and help regulate and modulate the activity of brain cells, but similar molecules also can be […]

Covey named Taylor Distinguished Professor of Psychiatry

Douglas F. Covey, PhD, a leader in the development of a new class of drugs — neurosteroids — to treat mental illness, has been installed as the inaugural Andrew C. and Barbara B. Taylor Distinguished Professor of Psychiatry at Washington University School of Medicine in St. Louis. The professorship was established through a gift from […]

On the frontiers of psychiatry

Physician-scientists aim to reduce the impact of mental illness on society From the WashU Outlook Magazine… Up to one-third of the 16 million Americans with clinical depression don’t get relief from antidepressant drugs. As a result, they endure continuing sadness, problems with sleep, and often, difficulty concentrating, so that reading a book or functioning at […]